Physician profile
Anuja A Pradhan
NPI 1528260064
$563.64
in general payments reported to CMS, 2019-2025
17 companies · $38.83 in 2025
The $38.83 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $92.13 · 2022: $98.55 · 2023: $26.84 · 2024: $193 · 2025: $38.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $114.19 | 2019 | |
| Glaxosmithkline, LLC. | $61.82 | 2022-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $56.81 | 2024 | Andexxa |
| Inquis Medical, INC. | $54.55 | 2024 | |
| Mindray Ds USA, INC. | $44.81 | 2024 | Te7 Max, Te X |
| Insmed, INC. | $35.58 | 2022-2025 | Arikayce |
| Medtronic, INC. | $26.18 | 2021 | |
| Boston Scientific Corporation | $22.62 | 2022 | |
| Electromed, INC. | $20.13 | 2021 | |
| Abiomed | $20.07 | 2024 | Impella |
| Philips North America LLC | $17.55 | 2021 | |
| Abbvie INC. | $16.97 | 2022 | |
| Merck Sharp & Dohme LLC | $16.86 | 2024 | Winrevair |
| Amgen INC. | $15.51 | 2022 | |
| Jazz Pharmaceuticals INC. | $14.71 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.56 | 2021 | |
| United Therapeutics Corporation | $11.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuja Pradhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.